Stocktoria
CHAMPIONS ONCOLOGY, INC. CSBR
CHAMPIONS ONCOLOGY, INC. financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.4M | $56.9M | $50.2M | $53.9M | $49.1M | $41.0M | $32.1M | $27.1M | $20.2M | — |
| R&D expense | $9.1M | $6.8M | $9.5M | $11.5M | $9.4M | $7.2M | $5.9M | $4.8M | $4.4M | $4.3M |
| Operating income | -$1.1M | $4.6M | -$7.4M | -$5.3M | $607,000 | $366,000 | -$1.9M | $270,000 | -$1.4M | -$6.8M |
| Income tax | $246,000 | -$75,000 | -$32,000 | $68,000 | $35,000 | $75,000 | $130,000 | $103,000 | $33,000 | $19,000 |
| Net income | -$1.2M | $4.7M | -$7.3M | -$5.3M | $548,000 | $362,000 | -$2.1M | $128,000 | -$1.5M | -$6.9M |
| EPS (diluted) | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 | $0.02 | $-0.18 | $0.01 | $-0.13 | — |
| Operating cash flow | -$4.5M | $7.4M | -$6.1M | $4.0M | $6.5M | -$1.7M | $2.9M | $1.9M | -$1.2M | -$2.8M |
| Free cash flow | -$5.0M | $7.0M | -$7.0M | $1.1M | $4.1M | -$5.0M | $685,000 | $1.0M | -$2.5M | -$3.6M |
| Cash & equivalents | — | $9.8M | $2.6M | $10.1M | $9.0M | $4.7M | $8.3M | $3.2M | $856,000 | $3.3M |
| Total assets | $27.0M | $32.3M | $26.1M | $34.3M | $35.4M | $27.6M | $20.8M | $11.3M | $8.1M | $8.0M |
| Total liabilities | $22.9M | $28.6M | $28.0M | $29.7M | $26.3M | $20.2M | $15.7M | $9.0M | $8.1M | $7.6M |
| Shareholders' equity | $4.1M | $3.8M | -$1.9M | $4.6M | $9.1M | $7.4M | $5.1M | $2.1M | $3,000 | $400,000 |
Growth · year-over-year · Revenue CAGR 14.4%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +4.4% | +13.5% | -6.9% | +9.7% | +19.7% | +27.8% | +18.7% | +33.7% | — | — |
| Net income growth | -125.0% | — | — | -1073.5% | +51.4% | — | -1735.2% | — | — | — |
| EPS growth | -124.2% | — | — | -1075.0% | +100.0% | — | -1900.0% | — | — | — |
| Free cash flow growth | -172.0% | — | -733.9% | -73.3% | — | -824.4% | -33.4% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.